Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Regularly reviewing your retirement plan is essential for long-term success. Find out when to make those important assessments.
20,077 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
As 2025 earnings season unfolds, AvePoint faces a pivotal moment in cloud data governance and SaaS expansion. This gu...
Rigetti Computing shares slid in a choppy week as inflation jitters and noisy peers weighed on sentiment. This guide ...
As 2026 unfolds, four online real estate schools rise to the top for licensing education, offering flexible formats, ...
February brought a notable rally for shares altria group stock. This article breaks down the drivers, the risks, and ...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
A major trading move shows Clearline Capital expanding its Core Scientific holding just as Bitcoin mining evolves int...
Marvell Technology is due to report Q4 results after the bell, with investors watching whether the company can beat e...
A fresh federal study reveals stubbornly low starting salaries for graduates in critical fields. Here’s what it means...
KAST announces an $80 million Series A led by QED Investors and Left Lane Capital, valuing the stablecoin fintech at ...
Gas prices rose amid tensions in the Middle East, rattling households and testing the political promises of energy co...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...